Condition: Cutaneous Squamous Cell Carcinoma (CSCC) · Cutaneous Squamous Cell Cancer · Cutaneous Squamous Cell Carcinoma of the Head and Neck · Sponsor: The Netherlands Cancer Institute
The goal of this clinical trial is to determine whether cutaneous squamous cell carcinoma patients can be cured using only immunotherapy, without surgery or radiotherapy.
This description comes directly from the study's public registry record.
Lotje Zuur, Prof. Dr. · +31205129111 · c.zuur@nki.nl
Stan W. van Dijk, MD · +31205129111 · matisse2@nki.nl
Always discuss trial participation with your own doctor first.
| Maastricht UMC | Maastricht, Limburg, Netherlands | Not Yet Recruiting |
| Netherlands Cancer Institute - Antoni van Leeuwenhoek | Amsterdam, North Holland, Netherlands | Recruiting |
| Amsterdam UMC | Amsterdam, North Holland, Netherlands | Not Yet Recruiting |
| Erasmus MC | Rotterdam, South Holland, Netherlands | Not Yet Recruiting |
| UMC Utrecht | Utrecht, Utrecht, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06823479